M D Cridland. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useBurkitt Lymphoma/drug therapyCarcinoma/drug therapyChoriocarcinoma/drug therapyDysgerminoma/drug therapyFemaleHead and Neck Neoplasms/drug therapyHodgkin Disease/drug therapyHumansImmunosuppressive Agents/therapeutic useKineticsLeukemia/drug therapyLeukemia, Lymphoid/drug therapyLeukemia, Myeloid/drug therapyLeukemia, Myeloid, Acute/drug therapyLymphoma, Follicular/drug therapyLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Non-Hodgkin/drug therapyMultiple Myeloma/drug therapyOvarian Neoplasms/drug therapyPolycythemia Vera/drug therapyPregnancyPrimary Myelofibrosis/drug therapyWilms Tumor/drug therapy
Substances: See more » Antineoplastic AgentsImmunosuppressive Agents
Year: 1972 PMID: 4347084 DOI: 10.2165/00003495-197203050-00003
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546